38
Views
29
CrossRef citations to date
0
Altmetric
Article

Suv39h1 Mediates AP-2α-Dependent Inhibition of C/EBPα Expression during Adipogenesis

, , , , , , , & show all
Pages 2330-2338 | Received 14 Jan 2014, Accepted 05 Apr 2014, Published online: 20 Mar 2023
 

Abstract

Previous studies have shown that CCAAT/enhancer-binding protein α (C/EBPα) plays a very important role during adipocyte terminal differentiation and that AP-2α (activator protein 2α) acts as a repressor to delay the expression of C/EBPα. However, the mechanisms by which AP-2α prevents the expression of C/EBPα are not fully understood. Here, we present evidence that Suv39h1, a histone H3 lysine 9 (H3K9)-specific trimethyltransferase, and G9a, a euchromatic methyltransferase, both interact with AP-2α and enhance AP-2α-mediated transcriptional repression of C/EBPα. Interestingly, we discovered that G9a mediates dimethylation of H3K9, thus providing the substrate, which is methylated by Suv39h1, to H3K9me3 on the C/EBPα promoter. The expression level of AP-2α was consistent with enrichment of H3K9me2 and H3K9me3 on the C/EBPα promoter in 3T3-L1 preadipocytes. Knockdown of Suv39h markedly increased C/EBPα expression and promoted adipogenesis. Conversely, ectopic expression of Suv39h1 delayed C/EBPα expression and impaired the accumulation of triglyceride, while simultaneous knockdown of AP-2α or G9a partially rescued this process. These findings indicate that Suv39h1 enhances AP-2α-mediated transcriptional repression of C/EBPα in an epigenetic manner and further inhibits adipocyte differentiation.

View publisher note:
Articles of Significant Interest Selected from This Issue by the Editors

SUPPLEMENTAL MATERIAL

Supplemental material for this article may be found at http://dx.doi.org/10.1128/MCB.00070-14.

ACKNOWLEDGMENTS

This work was supported by National Key Basic Research Project grants (2011CB910201 to Q. Q. Tang and 2013CB530601 and 2011CBA01103 to X. Li), National Natural Science Foundation grants (81270954 and 30870510 to X. Li), the National Natural Science Foundation of China (31030048 and 81390350 to Q. Q. Tang), the Shanghai Rising Star Program (13QH1400800 to X. Li), and the Shanghai New Excellent Medicine Talents Program (XYQ2011037 to X. Li). The Department of Biochemistry and Molecular Biology at Fudan University Shanghai Medical College is supported by Shanghai Leading Academic Discipline Project B110 and 985 Project 985III-YFX0302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.